Nanotechnology RSS feeds

ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN


copyright-Nanovip 2008

NANO FACTS

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide
nanotechnology companies | nanotechnology info Sheet Paper 100,000 nm wide

LATEST MEMBERS

  • lisa richards
  • tokmik
  • PamelSMIT
  • pramodl
  • rrichter
  • nanovipstaff

WHO'S ONLINE

There are currently 0 users and 13 guests online.

  Valid XHTML 1.0 Transitional

Button for your site

Authentix


Address: 4355 Excel Parkway, Suite 100
Zip: 75001

Visit this link

Phone :
+1 (866) 434 1402 (toll-free), +1 (469) 737 4400

Fax :
+1 (469) 737 4409

Formed by the merger of Isotag, Biocode and Calyx in 2003, Authentix combines 20 years experience in providing comprehensive services and technology for the prevention of product counterfeiting, brand adulteration and product diversion. In the last 3 years alone we have recovered nearly $3 billion in lost sales and tax revenues for clients. We are the market leader for authentication and product tracking in the oil and gas industry, and are poised to lead the pharmaceuticals, spirits, agrochemical and government security industries.

Within our portfolio, Authentix has an extensive range of patented technologies for on-package and in-product authentication, including regulatory approved forensic markers for ingestible products such as pharmaceuticals, foods and beverages. The range also includes both overt and covert security inks for field and laboratory authentication. The company has extensive experience in managing in-market testing programs for clients to ensure brand and distribution integrity for a total authentication service including; risk analysis, solutions design, program implementation and legal case management to ensure effective remediation.

» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page